Valuation
- Market cap
- 5,229,000
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 4,900
- Avg volume
- 44,142
- Day's range
- $0.03 – $0.03
- Shares out
- 171,439,000
- Stochastic %K
- 48%
- Beta
- 1.88
- Analysts
- —
- Price target
- —
Company profile
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions...
Show more
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions Inc. in May 2025. The company is based in Las Vegas, Nevada.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 888-225-0870
- Website
- https://cardiacbiotech.com
- Address
- 10845 Griffith Peak Drive, Suite 200, Las Vegas, United States
Latest news
No headlines yet.
